Mutation-specific Therapy for the Long QT Syndrome
NCT04581408
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Long QT Syndrome
Interventions
DRUG:
Lumacaftor / Ivacaftor, Orkambi® Oral Tablet
Sponsor
Istituto Auxologico Italiano